• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biofrontera AG

+ Add to Watchlist

B8F:GR

2.161 EUR 0.019 0.89%

As of 06:15:10 ET on 09/17/2014.

Snapshot for Biofrontera AG (B8F)

Open: 2.197 Day's Range: 2.150 - 2.249 Volume: 999
Previous Close: 2.142 52wk Range: 2.120 - 4.148 1-Yr Rtn: -38.78%

Stock Chart for B8F

No chart data available.
  • B8F:GR 2.244
  • 1D
  • 1M
  • 1Y
2.142
Interactive B8F Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B8F

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.4950
Est. EPS (EUR) (12/2014) -0.4630
Est. PEG Ratio -
Market Cap (M EUR) 47.97
Shares Outstanding (M) 22.20
30 Day Average Volume 18,582
Price/Book (mrq) -
Price/Sale (ttm) 14.0888
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B8F

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for B8F

Biofrontera AG develops drugs for dermatological and inflammatory diseases.

Hermann LuebbertChairman-Mgmt BoardThomas SchafferCFO/Member-Mgmt Board
More Company Profile & Key Executives for B8F

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil